THE NALOXONE EYE-DROP TEST FOR OPIOID DEPENDENCE
Saved in:
DORE, G.M., ET AL., THE NALOXONE EYE-DROP TEST FOR OPIOID DEPENDENCE. DRUG AND ALCOHOL REVIEW, Vol. 18, no. 2 (1999), p. 207-211.
Ref.
79088
Location:
SIIS R.1025 Archivo
Palabras clave:
Detección, Drogodependencias, Metodología, Opiáceos, Resultados
Detección, Drogodependencias, Metodología, Opiáceos, Resultados
Similar Items: THE NALOXONE EYE-DROP TEST FOR OPIOID DEPENDENCE
- The impact of the opioid antagonist naloxone on experimentally induced craving in nicotine-dependent individuals
- Rethinking retention in treatment of opioid dependence—The eye of the beholder
- OPIOID DETOXIFICATION USING NALOXONE
- The association between cocaine use and treatment outcomes in patients receiving of ce-based buprenorphine/naloxone for the treatment of opioid dependence
- Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
- THRICE WEEKLY SUPERVISED DOSING WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET IS PREFERRED TO DAILY SUPERVISED DOSING BY OPIOID-DEPENDET HUMANS